4 studies found for:    cudc-101
Show Display Options
Rank Status Study
1 Terminated Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Orally Administered CUDC-101 in Cancer Patients
Condition: Cancer
Intervention: Drug: CUDC-101
2 Completed A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors
Conditions: Head and Neck Cancer;   Liver Cancer;   Breast Cancer;   Gastric Cancer;   Non-Small Cell Lung Cancer
Intervention: Drug: CUDC-101
3 Active, not recruiting Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: CUDC-101;   Drug: Cisplatin;   Radiation: Radiation Therapy
4 Completed A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid Tumors
Condition: Tumors
Intervention: Drug: CUDC-101

Indicates status has not been verified in more than two years